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RESEARCH ARTICLE

Open Access

The effect of changes in intraocular pressure
on the risk of primary open-angle glaucoma
in patients with ocular hypertension: an
application of latent class analysis
Feng Gao1*, J Philip Miller1, Stefano Miglior3, Julia A Beiser2, Valter Torri4, Michael A Kass2 and Mae O Gordon1,2

Abstract
Background: Primary open-angle glaucoma (POAG) is one of the leading causes of blindness in the United States
and worldwide. While lowering intraocular pressure (IOP) has been proven to be effective in delaying or preventing
the onset of POAG in many large-scale prospective studies, one of the recent hot topics in glaucoma research is
the effect of IOP fluctuation (IOP lability) on the risk of developing POAG in treated and untreated subjects.
Method: In this paper, we analyzed data from the Ocular Hypertension Treatment Study (OHTS) and the European
Glaucoma Prevention Study (EGPS) for subjects who had at least 2 IOP measurements after randomization
prior to POAG diagnosis. We assessed the interrelationships among the baseline covariates, the changes of
post-randomization IOP over time, and the risk of developing POAG, using a latent class analysis (LCA) which allows
us to identify distinct patterns (latent classes) of IOP trajectories.
Result: The IOP change in OHTS was best described by 6 latent classes differentiated primarily by the mean IOP
levels during follow-up. Subjects with high post-randomization mean IOP level and/or large variability were more
likely to develop POAG. Five baseline factors were found to be significantly predictive of the IOP classification
in OHTS: treatment assignment, baseline IOP, gender, race, and history of hypertension. In separate analyses of
EGPS, LCA identified different patterns of IOP change from those in OHTS, but confirmed that subjects with high
mean level and large variability were at high risk to develop POAG.
Conclusion: LCA provides a useful tool to assess the impact of post-randomization IOP level and fluctuation on the
risk of developing POAG in patients with ocular hypertension. The incorporation of post-randomization IOP can
improve the overall predictive ability of the original model that included only baseline risk factors.
Keywords: Latent class analysis, Longitudinal data, Time-dependent covariate, Prediction model, Survival data,
Primary open-angle glaucoma, Intraocular pressure fluctuation

Background
Ocular hypertension is a leading risk factor for the development of primary open-angle glaucoma (POAG)
which remains one of the major causes of blindness in
the United States and worldwide [1-5]. It is estimated
that approximately 4% - 7% of the population over the
age of 40 years have ocular hypertension without detectable glaucomatous damage using standard clinical
* Correspondence: feng@wustl.edu
1
Division of Biostatistics, Washington University School of Medicine, St. Louis,
MO 63110, USA
Full list of author information is available at the end of the article

tests, and thus as many as 3 to 6 million Americans
are at risk for developing glaucoma because of ocular
hypertension [6-8]. Intraocular pressure (IOP) is the
only known modifiable risk factor for POAG. Lowering
the level of IOP has been shown to effectively delay or
prevent glaucomatous visual damage in different
phases of disease progression by many large-scale multicenter clinical trials, including the Ocular Hypertension Treatment Study (OHTS) [9], the Early Manifest
Glaucoma Trial [10], and the Advanced Glaucoma
Intervention Study [11].

© 2012 Gao et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.

Gao et al. BMC Medical Research Methodology 2012, 12:151
http://www.biomedcentral.com/1471-2288/12/151

In recent years, one of the hot topics in glaucoma
research has been the effect of IOP fluctuation (IOP
lability), both within a single day (short-term fluctuation) and from visit to visit (long-term fluctuation) on
POAG [12,13]. Measures of IOP fluctuation have
included a wide range of quantities - peak, trough,
variance, and range, etc. [13] However, since subjects
with high mean IOP often show large IOP variability
over time, it is challenging to disentangle the effect of
fluctuation from mean IOP. A recently emerged technique for longitudinal data analysis, latent class analysis
(LCA) [14], provides an appealing approach to this
question. Rather than dealing with individual measures
of fluctuation, LCA identifies distinct patterns of longitudinal profiles based on the combination of summary
statistics (i.e., mean level and variability) and hence
provides information complementary to the conventional methods. LCA uses the patterns of serial biomarker readings available for subjects, together with
baseline covariates and disease outcomes, to divide
subjects into a number of mutually exclusive subpopulations (classes). The class membership is unobserved
(latent) and determined by the class-specific parameters
in a data-driven basis.
In this paper, we used LCA to model the postrandomization IOP in the OHTS. For each class, the
change of IOP was characterized by 4 parameters: the
initial IOP level (I), the linear (L) and quadratic (Q)
trend over time, and the variance of IOP (V). We used
data from the European Glaucoma Prevention Study
(EGPS) [15], another large-scale multicenter randomized clinical trial of patients with ocular hypertension,
for external independent validation. We first fit an unconditional (without any covariates) LCA to determine
the optimal number of distinct patterns that best
described the IOP change for each study. Then a conditional model was constructed by adding baseline covariates as the antecedents (predictors) of IOP change and
time to POAG as a consequence (outcome) of IOP
change [16]. This analysis enhanced our understanding
of the interrelationships among the IOP change, the
baseline covariates, and the risk of developing POAG.
This also provided evidence towards our ultimate goal
to improve the prediction of POAG in patients with
ocular hypertension.

Methods
Study cohort

Our study used data from OHTS and EGPS, the two
largest randomized trials to test safety and efficacy of
topical hypotensive medication in preventing the development of POAG. In OHTS, 1636 subjects were randomized to either observation or treatment with ocular
hypotensive medication and followed for a median of
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78 months [9]. In EGPS, 1077 subjects were randomized
to either placebo or an active treatment (dorzolamide)
and followed for a median of 55 months [15]. The two
studies shared many key similarities in the study protocol and generated data of high quality. In both studies,
for example, the outcome ascertainment was performed
by specialized resource centers where readers were
masked as to randomization assignment and information about the participant’s clinical status, and the attribution of abnormality due to POAG was performed by
a masked Endpoint Committee. Detailed information on
the similarity and discrepancy between OHTS and
EGPS as described by Gordon et al. [17]. This study
was approved by the Institutional Review Boards of
Washington University in St. Louis and the University
Bicocca of Milan.
In this paper, we excluded IOP values measured after
POAG onset. The primary endpoint was time from
randomization to the development of POAG. Those subjects who did not develop POAG were censored at the
date of study closeout. In addition to the follow-up data,
following 13 demographic and clinical characteristics at
randomization were also included in this paper: treatment assignment (TRT, 0 for observation/placebo and 1
for treatment), male gender (Male), black race (Black),
age at randomization (Age, decade), baseline IOP (IOP0,
mmHg), central corneal thickness (CCT, μm), pattern
standard deviation (PSD, dB), vertical cup/disc ratio
(VCD), the use of systematic beta blocker (BB) or Calcium channel blockers (CHB), and the history of diabetes (DM), heart diseases (Heart), or hypertension
(HBP). These baseline factors were identified a priori as
possible predictors for the development of POAG during
the planning phase of the OHTS [18]. We excluded 34
subjects from EGPS with pigment dispersion and exfoliation syndromes (an exclusion criterion in OHTS). We
also excluded subjects without any follow-up data (18 in
OHTS and 47 in EGPS) or those with only 1 follow-up
visit (19 in OHTS and 25 in EGPS). Therefore, these
subjects with at least 2 follow-up visits (1600 from
OHTS and 971 from EGPS) constituted our study cohort for the unconditional LCA. In the conditional LCA,
we further excluded subjects without CCT measurements (169 in OHTS and 143 in EGPS) or those with
missing values in any other baseline factors (6 in EGPS).
Table 1 presented the summary statistics of baseline covariates and post-randomization data for each study,
where the binary data were summarized as counts and
proportions, while the continuous variables were summarized in means and standard deviations (SD). For
consistency with previous analyses [17,18], values for the
baseline eye-specific variables (CCT, PSD, VCD, and
baseline IOP) for each participant were the average
of two eyes (with the exception of the EGPS participants

Gao et al. BMC Medical Research Methodology 2012, 12:151
http://www.biomedcentral.com/1471-2288/12/151

Page 3 of 13

Table 1 Summary statistics of baseline predictors and
follow-up data for OHTS and EGPS, where categorical
variables are summarized as counts and proportions,
while the continuous variables are summarized in
means and standard deviations (SD)
Variables

OHTS (N = 1600)

EGPS (N = 971)

latent classes, with i =1, 2, . . ., N, and g =1, 2, . . ., G, respectively. Then the distribution of Yi was a mixture distribution defined as [14],
f ðYi Þ ¼

795 (49.7%)

487 (50.2%)

Male

687 (42.9%)

445 (45.8%)

Black

396 (24.8%)

AGE (decades)

5.56 (0.96)

IOP0 (mmHg)

1 (0.1%)
5.70 (1.02)

24.9 (2.69)

23.4 (1.62)

572.6 (38.5)

573.3 (37.5)

PSD (dB)

1.91 (0.21)

2.00 (0.52)

VCD

0.39 (0.19)

0.32 (0.14)

G
X

71 (4.4%)

64 (6.6%)

h¼1

CHB

190 (11.9%)

66 (6.8%)

DM

188 (11.8%)

55 (5.7%)

Heart

99 (6.2%)

109 (11.2%)

HBP

606 (37.9%)

279 (28.7%)

Post-randomization IOP
Mean (mmHg)
SD (mmHg)
Median #visits (min-max)
POAG

21.44 (3.45)

19.73 (2.57)

2.27 (1.04)

2.22 (1.03)

13 (2–16)

9 (2–10)

146 (9.1%)

107 (11.0%)

with only one eye eligible for the study). For the
post-randomization IOP, however, only eye-specific data
were used because averaging two eyes could underestimate the true intra-patient IOP variability. We took advantage of the fact that IOPs between two eyes were
highly correlated (with an intra-class correlation coefficient of 0.75), and follow-up IOPs were chosen from the
first eye developed POAG or an eye selected randomly in
participants without POAG. Since the continuous baseline
covariates were measured in quite different scales, they
were standardized to have mean 0 and variance 1 throughout the remainder of this paper. As such, for these variables the odds ratios (OR) and hazard ratios (HR) from
the regression models represented the effect per 1-SD
change.

Statistical analysis
Unconditional LCA

Suppose there were N subjects and each subject had ni
pre-POAG IOP measures. Let Yi = {Y1, Y2, . . .. . .} denote
the post-randomization IOP and Ci represent the latent
class membership of ith individual, and θg be the vector of
class-specific parameters that differentiate the G



ð1Þ

where PrðCi ¼ gÞ represented the size (mixing proportion)
of gth latent class in the mixture and


f ðYi Ci ¼ g; θg was the class-specific distribution of Yi
as detailed below.

CCT (μm)

BB



fPrðCi ¼ gÞ  f ðYi Ci ¼ g; θg g

g¼1

Baseline predictors
TRT

G
X

 The mixing probability PrðCi ¼ gÞ was modeled

as a multinomial logistic regression, PrðCi ¼ gÞ ¼
expðα0g Þ

, where α0g represented the log odds

expðα0g Þ

of membership in the gth class relative to a
reference class (class 1, say), with the parameter
in the reference being 0 for identification.

 The specification of f ðYi Ci ¼ g; θg was aided by
our previous experience on the joint modeling of
longitudinal IOP and time to POAG in OHTS [19].
The joint model identified IOP variability as an
independent predictor for POAG and also
revealed that the IOP change can be better fit by
a quadratic
functional
form. Therefore, we set


f ðYi Ci ¼ g; θg ¼ Ig þ Lg ti þ Qg ti2 þ Ei , with
Ei eNð0; Vg Þ and θg ¼ Ig ; Lg ; Qg ; Vg : Because
high IOP was an eligibility criterion in both
OHTS and EGPS, the estimated initial level
(intercept Ig) may be influenced by “regression to
the mean”. To address this concern, we re-set
the time 0 and the intercept was actually
estimated at 1-year after randomization. We also
assumed that follow-up IOPs were measured
regularly every 6 months according to the
protocol, i.e., with timing ti = {−0.5, 0, 0.5, 1, . . .}.
Figure 1A showed the diagram of an
unconditional LCA for the OHTS data.
_
 Given the estimated parameters θ g and the
observed IOP, each individual can be assigned to the
most likely class based on the probability of class
membership (often termed as posterior class
probability) [14],
_
_
PrðCi ¼ gÞ  f ðYi jCi ¼ g; θ g Þ
 pig ¼ G
X _

_ 
PrðCi ¼ hÞ  f ðYi Ci ¼ h; θ h g:
h¼1

The best unconditional LCA was selected by enumerating and comparing a set of competing models differing
only in the number of classes. In this paper, the model
comparison was based primarily on the log likelihood
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Figure 1 Diagrams for unconditional (1A) and conditional (1B) latent class analysis (LCA) for OHTS data, where C denoted the latent
classes. The trajectory of post-randomization IOP (Y) in each class was described by 4 class-specific parameters: the initial IOP level (I), the
systematic linear (L) and quadratic (Q) trend over time, and the variance of IOP (V).

values, including the Bayesian Information Criteria (BIC,
with a smaller BIC indicating a better fit) and the LoMendell-Rubin adjusted likelihood ratio test (LMR-LRT)
[20]. A significant test of LMR-LRT indicated that the
model with G-1 classes should be rejected in favor of
the G-class LCA. In addition to the above statistical criteria, we also specified a minimum size for each class
(with at least 5% participants in OHTS or 10% participants in EGPS) to ensure reliable within-class estimation. Once an optimal LCA was developed, a bootstrap
method was used to assess whether patients with different patterns of IOP change have different susceptibility
to POAG. Specifically, a class membership was generated for each individual from a multinomial distribution
using the posterior class probability, and then a Cox
model was fit to assess the effects of latent classes on
POAG. Summary statistics such as hazard ratios and
their 95% confidence intervals were estimated by repeating the above procedure 1,000 times.
Conditional LCA

Since patterns of IOP change were found to be associated with the risk of POAG in an unconditional LCA,
a conditional LCA was built by adding baseline covariates as predictors to the IOP change and adding time to
POAG as an outcome due to IOP change (Figure 1B).
Let Xi denote the baseline predictors for ith subject and
Ti = minimum(Di, Ui) be the observed time, where Di
was the time to POAG and Ui represented the censoring

time independent of Di . Let Δi be the corresponding
event indicator, with Δi = 1 if POAG is observed and
Δi = 0 otherwise. Let α and β denote effects of baseline
covariates Xi on the IOP change and time to POAG respectively. Then the joint distribution of (Yi , Ti) was a
mixture distribution defined as [21],
f ðYi ; Ti Þ ¼

G
X
fPrðCi ¼ g; αg Þ  f ðYi jCi ¼ g; θg Þ
g¼1

λðTi jCi ¼ g; βÞΔi  S ðTi jCi ¼ g; βÞg

ð2Þ

 Similar to Model (1), the term PrðCi ¼ g; αg Þ ¼

expðα0g þ αg Xi Þ

G
X

expðα0h þ αh Xi Þ

represented the size of gth class



in the mixture distribution and f ðYi Ci ¼ g; θg
described the within-class IOP change.
 The term λðTi jCi ¼ g; βÞ ¼ λ0g ðtÞ  expðβXi Þ
th
described the risk of developing
R POAG in g class
and SðTi jCi ¼ g; βÞ ¼ expð λ0g ðtÞ  expðβXi ðdtÞ
was the corresponding cumulative POAG-free
probability, where λ0g(t) was the class-specific
baseline hazard with all covariates being 0. In this
paper, λ0g(t) was approximated by a piece-wise
step-function with a 6-month interval. Following the
conventional practice in joint latent class modeling
[21,22], we assumed that the association between
IOP change and time to POAG was introduced
h¼1
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exclusively via λ0g(t), so that the longitudinal process
and survival process were completely independent
given the class membership. Therefore, neither
time-dependent IOP values nor random effects of
IOP were included in the survival function. We also
assumed that the effects of covariates on POAG
were common across latent classes.
The conditional LCA facilitated a better understanding
of ocular hypotensive treatment on the risk of developing POAG. This model allowed us to determine whether
the predictive accuracy on POAG can be improved by
adding post-randomization IOP. For example, the survival probability (cumulative POAG-free rate) at any
time t can be readily calculated as the average of the
class-specific survival weighted by the posterior class
probabilities,

S ðTi ¼ t Þ ¼

G
X
g¼1





^
^ ig  S^ Ti ¼ t Ci ¼ g; β
p

ð3Þ

with


_
^ g Þ  f ðYi Ci ¼ g; θ g
PrðCi ¼ g; α
^ ig ¼ G
p
X _


_ 
^ h  f ðYi Ci ¼ h; θ h g;
PrðCi ¼ h; α
_

h¼1

^
^ i ¼ tjCi ¼ g; βÞ
and SðT
!
Zt
^ i Þds ;
¼ exp  ^λ 0g ðsÞ  expðβX
s¼0

where


^ and ^λ 0g ðt ÞÞ were the estimated para^ g ; β;
θ^ g ; α

meters from the conditional LCA. In this paper, the parameter estimation for LCA was implemented using
statistical package Mplus [23], while all the other analyses were performed using statistical package R [24].

Results
Unconditional LCA

Table 2 showed the fitting statistics of 7 competing
LCAs for the OHTS and EGPS data. Based on the
model-selection criteria, the IOP change in OHTS was
best described by 6 distinct patterns (latent classes),
which included 13%, 28%, 20%, 10%, 18% and 11% of the
OHTS subjects respectively. Figure 2 showed the followup IOPs of 50 randomly selected subjects for each class.
Most classes were distinguished primarily by the mean
IOP levels. The only exceptions were classes 3 and 4.
Classes 3 and 4 had similar average trajectories, but subjects in Class 4 showed a much larger variability. Figure 2
also indicated that the classes with higher mean level
and/or larger variability had a higher risk of developing
POAG. Table 3 reported the observed frequency of
POAG in each class based on the most likely class membership. The hazard ratio (HR) and its 95% confidence
interval (CI) of developing POAG in each class were also
calculated using 1000 bootstrapping samples to account
for the uncertainty in class membership. The results
showed that the last 3 classes had significantly higher
risk of developing POAG than the first 3 classes. For
reasons that were not clear, however, subjects in Class 2
had the smallest risk though the subjects in Class 1 had
the lowest mean follow-up IOP.
In EGPS, the IOP change was best fit by a 5-class LCA
(Table 2). Figure 3 showed the post-randomization IOPs
of 50 randomly selected subjects from each of the 5
classes, which included 25%, 19%, 28%, 16% and 12% of
EGPS subjects respectively. Subjects in classes 1 and 2
started with similar initial follow-up IOP levels, but
those in Class 2 showed a relatively rapid decrease over
time. Similarly, subjects in classes 3 and 4 had similar
initial levels, but subjects in Class 4 showed a relatively
rapid decrease and subjects in Class 3 did not. All subjects in the first 4 classes presented similar magnitude of
IOP variability. Subjects in Class 5 had the highest mean
level and the largest variability, and they showed a significantly higher risk than the other 4 classes (Table 3).

Table 2 Fitting statistics of 7 competing models that are only different in the number of latent classes
# latent classes (G)

OHTS
BIC

EGPS

LMR-LRT*

Minimal class size

BIC

LMR-LRT

Minimal class size

2

97097

<0.001

47%

39235

<0.001

44%

3

94219

0.002

24%

38395

0.001

14%

4

92922

0.609

14%

38109

0.005

11%

5

92107

0.003

13%

37870

0.009

12%

6

91644

0.042

10%

37760

0.452

9%

7

91289

0.147

7%

37682

0.060

5%

8

91045

0.406

6%

37608

0.011

4%

* Lo-Mendell-Rubin likelihood ratio test, with a smaller p-value favoring the G-class model over the model with G-1 classes (null hypothesis).
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0
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4
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2
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Follow−up IOP (mmHg)

0
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30

40

I=17.5

Class 2 (28%)

10

Follow−up IOP (mmHg)
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0

2

4

Years after randomization

Figure 2 Post-randomization IOP values for 50 subjects randomly selected from each of the 6 latent classes indentified in OHTS, where
red lines represented subjects who developed POAG and the black lines were for those without POAG. The class membership was based
on the posterior probabilities from the optimal unconditional LCA, and the 4 parameters (I, L, Q, and V) in the plots represented the estimated
initial level, the systematic linear and quadratic trend over time, and the variance of post-randomization IOP respectively.

Table 4 presented the distribution of treatment groups
across latent classes in the OHTS and EGPS data respectively. In OHTS a great majority of subjects from
treatment group fell into the first 3 classes, while in
EGPS the distributions of treatment groups were rather
similar across all latent classes.
Conditional LCA

A conditional model was constructed for OHTS and
EGPS separately by adding the baseline factors as predictors and the time to POAG as the outcome to the optimal unconditional LCAs (Figure 1B). Since we had an
adequate sample size in both studies, no variable-

selection procedure was performed and all the baseline
covariates (with the exception of dropping the variable
race Black from EGPS because of lack of racial diversity)
were included as predictors for both IOP change and the
risk of developing POAG. Figure 4 presented the modelbased predicted cumulative incidence for an “average”
person with all baseline covariates being zero. After controlling for baseline covariates, different patterns of IOP
change continued to be prognostic of POAG development. In both studies, the class with the highest mean
level was most likely to develop POAG after adjusting
for baseline IOP. In OHTS, subjects in Class 4 (with a
moderate mean IOP and the largest variability) had
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Table 3 Observed proportions of POAG, as well as
estimated hazard ratios (HR) and 95% confidence
intervals (CI) for POAG development in the unconditional
LCAs for the OHTS and EGPS data, where the HR and
95% CI were based on 1000 bootstrapping samples to
account for the uncertainty in the latent class
membership
Latent class

OHTS

EGPS

POAG%

HR

POAG%

HR

1

5.9%

1.00

95% CI
-

8.3%

1.00

95% CI
-

2

3.9%

0.59

0.37 - 0.88

10.2%

1.28

0.76 - 2.06

3

4.3%

0.83

0.57 - 1.14

8.7%

1.13

0.73 - 1.65

4

10.1%

1.87

1.32 - 2.57

10.5%

1.40

0.85 - 2.18

5

11.4%

1.93

1.50 - 2.46

19.4%

2.66

1.92 - 3.69

6

31.2%

5.61

4.46 - 7.08

similar risk as those in Class 5 (with a higher mean IOP
and much less variability), but showed a higher risk than
those in Class 3 (with the mean IOP comparable to
Class 4 but with much less variability). In EGPS, the first
4 classes showed similar risk of developing POAG.
Table 5 presented the estimated parameters for withinclass IOP trajectories, as well as the effects of baseline
covariates on IOP classification and the risk of POAG
development.
Effects of the baseline covariates on IOP classification
 To identify baseline predictors for IOP classification,

we only focused on factors that were significantly
associated with the high risk groups (Classes 4, 5, 6
in OHTS, and Class 5 in EGPS), while treating the
lowest risk group (Class 2 in OHTS and Class 1 in
EGPS) as the reference. In OHTS, treatment
assignment and baseline IOP were two most
important predictors for IOP classification. Subjects
randomized to treatment group had a much lower
chance of inclusion in the high risk groups (with
OR = 0.11, 0.003, and 0.002 for Classes 4, 5, and 6,
respectively), while these with a higher baseline IOP
were more likely to be in the Classes 4, 5, or 6 (with
OR = 2.80, 2.44, and 5.64 respectively). The results
also showed that male subjects were less likely to be
in Class 5 (OR = 0.51), the black subjects were more
likely to be in Class 4 (OR = 2.12) but with a lower
chance in Class 5 (OR = 0.40), and subjects with a
history of hypertension were more likely in Class 6
(OR = 1.93). In EGPS, the results confirmed that
treatment assignment (OR = 0.17) and baseline IOP
level (OR = 5.99) were important predictors for
Class 5. The result also showed that older age
(OR = 1.57) was significantly associated
with Class 5.

Effects of the baseline covariates on the risk of POAG
development
 As expected, the effects of baseline covariates on the

risk of developing POAG from the conditional LCA
reached consistent conclusions as previous analyses
using Cox models [17,25]. In OHTS, subjects with
older age (HR = 1.20), higher PSD (HR = 1.26), large
VCD (HR = 1.82), and history of heart diseases
(HR = 2.03) had a higher risk of developing POAG,
while thicker CCT (HR = 0.53) and history of
diabetes (HR = 0.19) reduced the risk of developing
POAG. Interestingly, despite marked differences
between OHTS and EGPS in the patterns of IOP
change, the EGPS confirmed 4 of the 6 predictors
(except age and history of diabetes) identified in
OHTS. In both studies, baseline IOP and treatment
assignment were not significantly associated with
POAG directly, but appeared to affect the risk
indirectly through their strong influence on the
classification of IOP change.
To explore the effect of follow-up IOP on the overall
predictive accuracy of POAG, the 5-year cumulative
POAG incidence was calculated for each individual
using the formula (3). The overall predictive accuracy
was summarized as C-index and calibration statistics
(Model 1 in Table 6) [26]. For comparison, Table 6 also
presented the C-index and calibration statistics from
Cox models that only incorporated baseline predictors
(Model 0). The results showed that adding postrandomization IOP considerably improved the predictive
accuracy on POAG. In OHTS, for example, C-index
increased from 0.778 to 0.821 by adding follow-up IOP.
Given the fact that C-index from the baseline model was
already high and there was little room for improvement,
such an increase was substantial. An improvement in
the C-index was also observed in EGPS though in a
much smaller magnitude (from 0.706 to 0.719). The calibration statistics indicated that the model-based and
observed survival probabilities were well agreed in both
OHTS (X2 = 11.3) and EGPS (X2 = 7.0).
Sensitivity analyses

As in all the statistical models, LCAs were inevitably
based on certain assumptions. One assumption of our
LCA was that the trajectories of IOP followed a quadratic functional form. It is known that the parameter
estimates, class sizes, and interpretation of latent classes
could be heavily influenced by the within-class distribution of longitudinal data [16]. In this section, first we
assessed the sensitivity of risk prediction to different
LCA specifications. Table 6 presented the C-index and
calibration statistics for LCAs after removing the
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Figure 3 Post-randomization IOP values for 50 subjects randomly selected from each of the 5 latent classes indentified in EGPS, where
red lines represented subjects who developed POAG and the black lines were for those without POAG. The class membership was based
on the posterior probabilities from the optimal unconditional LCA, and the 4 parameters (I, L, Q, and V) in the plots represented the initial level,
the systematic linear and quadratic trend over time, and the variance of post-randomization IOP respectively.

Table 4 Distribution of the randomization groups across latent classes, where the latent classes were based on the
most likely posterior class probability from the optimal unconditional LCAs for the OHTS and EGPS data
Latent class

OHTS

EGPS

Observation

Treatment

Placebo

Treatment

15 (1.9%)

191 (24.0%)

113 (23.3%)

143 (29.4%)

2

67 (8.3%)

385 (48.4%)

69 (14.3%)

112 (23.0%)

3

226 (28.1%)

106 (13.3%)

162 (33.5%)

136 (27.9%)

4

55 (6.8%)

84 (10.6%)

64 (13.2%)

63 (12.9%)

5

279 (34.7%)

19 (2.4%)

76 (15.7%)

33 (6.8%)

6

163 (20.2%)

10 (1.3%)

Total

805 (100%)

795 (100%)

1

484 (100%)

487 (100%)
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Figure 4 Predicted baseline cumulative incidence of POAG for each class, based on the conditional latent class analysis for the OHTS
and EGPS data respectively.

quadratic term (Model 2) or removing both quadratic
and linear terms (Model 3). The results showed that
LCAs had a robust performance in terms of predictive
accuracy for POAG development.
Next, two additional sensitivity analyses were performed in the OHTS data, one excluding participants
with Black race and the other only using participants
randomized to the observation group. The IOP change in
the non-Black was best described by 6 distinct classes,
while the LCA in the untreated participants identified 5
classes. Figures 5A and 5C showed the observed mean
IOP of latent classes in the non-Black and untreated participants, respectively. Although most classes were distinguished primarily by the mean IOP, each LCA identified
a subgroup of participants (Class 4) who had a moderate
IOP mean but with the highest IOP variability. More
interestingly, the participants from Class 4 in both LCAs
showed relatively higher risk of POAG development than
those with a comparable mean IOP (Figures 5B and 5D).
Finally, our LCA also made an implicit assumption
that the baseline covariates influenced the IOP change
exclusively through their effects on the class membership (i.e., no direct effects on the within-class growth
parameters). The validity of this assumption can be

checked by comparing the conditional LCAs with the
unconditional models. The assumption violation is often
signified by a dramatic shifting in the meaning and size
of latent classes when the baseline predictors are added
to the unconditional LCA [16]. Based on the estimated
class-specific parameters (Table 5, Figures 2 and 3), this
assumption was well satisfied in both studies.

Discussion
In recent years, one of the hot topics in glaucoma research has been the effect of IOP fluctuation on POAG.
Although more and more studies have confirmed that a
decrease in the mean IOP level can reduce the risk of
developing POAG, the findings from major prospective
clinical trials about the impact of IOP fluctuation on
POAG remain controversial [25,27-30]. In this paper, we
analyzed the post-randomization IOPs from OHTS and
EGPS taking a latent class analysis (LCA) approach. The
LCA allows us to identify distinct patterns of IOP
change over time and then associates the changes in
IOP with the risk of POAG. The results from both studies showed that different patterns of IOP change could
markedly affect the risk of POAG (irrespective of their
baseline, pre-randomization IOP levels). In OHTS, the
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Table 5 Estimated parameters of the conditional LCAs in the OHTS and EGPS data
OHTS
Variables

Parameters for IOP change and the effects of covariates on class membership

Effects on
POAG

Class 1

Class2 (Ref.)

Class 3

Class 4

Class 5

Class 6

14.2%

27.1%

21.1%

9.1%

17.6%

10.9%

I

17.58(0.20)#

19.83(0.21)#

22.30(0.21)#

22.82(0.79)#

24.74(0.22)#

27.70(0.28)#

Class Size
IOP Change

-

L

−0.57(0.08)

−0.53(0.06)

−0.47(0.09)

−0.95(0.30)

−0.20(0.09)*

0.16(0.17)

-

Q

0.06(0.01)#

0.05(0.01)#

0.05(0.01)#

0.07(0.04)

0.02(0.02)

−0.05(0.03)

-

V

4.36(0.27)#

4.30(0.32)#

4.80(0.25)#

16.07(1.46)#

4.66(0.31)#

12.15(1.15)#

-

2.08(0.47)#

−0.06(0.47)

2.35(0.54)#

#

#

#

#

#

Covariates
Intercept

−2.64(0.63)#

1.04(0.61)

-

TRT

*

1.60(0.66)

-

−3.25(0.35)

−2.19(0.63)

−5.98(0.56)#

−6.46(0.70)#

0.16(0.29)

MALE

0.25(0.23)

-

−0.99(0.24)#

0.24(0.27)

−0.68(0.28)*

−0.22(0.30)

0.23(0.19)

RACEB

−0.10(0.27)

-

−0.37(0.30)

*

0.75(0.31)

*

−0.91(0.34)

0.05(0.37)

−0.05(0.24)

AGE

0.06(0.12)

-

−0.01(0.12)

0.08(0.16)

−0.05(0.14)

0.13(0.15)

0.18(0.09) *

*

#

#

#

IOP0

#

−0.79(0.18)

-

0.21(0.22)

1.03(0.36)

0.89(0.18)

1.73(0.22)

−0.10(0.11)

CCT

−0.35(0.12)*

-

0.18(0.11)

−0.08(0.17)

0.14(0.13)

0.09(0.16)

−0.64(0.13)#

PSD

0.13(0.11)

-

0.04(0.11)

0.08(0.13)

0.17(0.13)

0.12(0.15)

0.23(0.10)*

VCD

0.06(0.11)

-

−0.08(0.12)

−0.15(0.17)

−0.10(0.13)

−0.09(0.15)

0.60(0.10)#

BB

−0.60(0.48)

-

−0.37(0.61)

−0.30(0.62)

−1.21(0.77)

0.19(0.57)

CHB

−0.19(0.37)

-

−0.32(0.42)

0.47(0.45)

−0.42(0.44)

−0.50(0.49)

0.09(0.31)

DM

−0.23(0.35)

-

0.22(0.32)

−0.71(0.45)

0.23(0.36)

0.64(0.40)

−1.67(0.53)*

HEART

0.70(0.44)

-

0.10(0.49)

0.43(0.56)

−0.09(0.56)

−0.48(0.73)

0.71(0.29)*

HBP

0.47(0.24)*

-

0.40(0.27)

0.06(0.34)

0.41(0.30)

0.66(0.33)*

0.08(0.22)

-

**

EGPS
Variables

Parameters for IOP change and the effects of covariates on class membership

Effects on POAG

Class1 (Ref.)

Class 2

Class 3

Class 4

Class 5

26.3%

20.1%

29.3%

12.9%

11.4%

I

18.66(0.25) #

18.24(0.18)#

21.24(0.20)#

21.85(0.47)#

24.33(0.34)#

-

L

−0.34(0.14)*

−1.29(0.18)#

−0.25(0.11)*

−1.76(0.28)#

0.06(0.26)

-

Q

0.05(0.03)

0.11(0.04)*

0.02(0.03)

0.02(0.07)

−0.08(0.07)

-

V

3.79(0.23)#

3.75(0.25)#

4.59(0.24)#

7.12(0.85)#

12.17(1.32)#

-

-

−0.84(0.33)*

0.30(0.28)

−0.85(0.58)

−0.71(0.34)*

-

-

0.36(0.27)

−0.65(0.23)

−0.58(0.37)

−1.79(0.37)#

−0.01(0.21)

MALE

-

−0.35(0.29)

0.14(0.23)

0.18(0.40)

0.38(0.33)

−0.24(0.22)

Black

-

-

-

-

-

-

AGE

-

−0.09(0.16)

0.01(0.13)

0.40(0.23)

0.45(0.20)

IOP0

-

−0.61(0.24)*

0.82(0.17)#

1.24(0.24)#

1.79(0.23)#

0.11(0.13)

CCT

-

−0.33(0.13)*

−0.14(0.12)

−0.43(0.15)*

0.09(0.15)

−0.36(0.12)*

PSD

-

0.27(0.16)

−0.23(0.14)

−0.18(0.24)

−0.41(0.23)

0.18(0.09)*

-

−0.13(0.17)

−0.03(0.13)

*

0.17(0.16)

0.46(0.12)#

BB

-

−0.17(0.50)

−0.82(0.52)

−0.58(0.69)

−0.07(0.41)

CHB

-

−0.10(0.56)

−0.97(0.52)

−1.22(0.79)

−0.28(0.47)

Class Size
IOP Change

Covariates
Intercept
TRT

VCD

*

0.72(0.26)
-

**

0.89(1.03)

*

0.16(0.10)

DM

-

−0.46(0.52)

0.12(0.45)

−1.32(1.27)

0.82(0.81)

−0.18(0.54)

HEART

-

0.78(0.41)

0.11(0.44)

−0.83(0.77)

−0.79(0.61)

0.74(0.32)*

HBP

-

0.02(0.36)

0.53(0.30)

−1.27(0.90)

0.11(0.54)

0.24(0.26)

*: p < 0.05; #: p < 0.001; **: Not estimable due to zero count of beta blocker use in the given class.
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Table 6 Sensitivity analysis comparing the overall predictive accuracy (measured as C-index and Calibration Chi-square
statistics) for LCAs with different model specifications
Model

Model Features

C index

Calibration Chi-square

OHTS

EGPS

OHTS

EGPS

0

Cox mode with baseline factors only

0.778

0.706

5.0

2.1

1

LCA with a quadratic within-class functional form

0.821

0.719

11.3

7.0

2

LCA with a linear within-class functional form

0.825

0.720

10.2

4.9

3

LCA with a constant within-class functional form

0.823

0.727

10.5

13.5

change in IOP was best described by 6 distinct patterns.
The model identified a subset of participants in whom
IOP variability also played an important role in predicting POAG. This subgroup showed the highest IOP
variability and had a higher risk than those with a comparable IOP mean. Comparing to the reference class,
these participants were less likely from treatment group
(OR = 0.11), more likely self-classified as being black
(OR = 2.12), and had relatively higher baseline IOP
(OR = 2.80). However, the subgroup only accounted for
about 10% of the OHTS sample, and this may partially
explain our finding that IOP variability was an independent risk factor in the OHTS but had little impact
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on the overall predictive accuracy for POAG (manuscript in progression). In a sensitivity analysis using the
non-Black participants, the LCA identified similar patterns of IOP change as in the whole OHTS dataset. This
result was consistent with a tree-based model in the
OHTS-EGPS meta-analysis which showed that race was
no longer an important predictor for POAG development after considering other risk factors [17]. In EGPS,
LCA identified 5 distinct latent classes and confirmed
that those subjects with the highest mean IOP were
most likely to develop POAG. However, it failed to disentangle the effect of fluctuation from mean because
these participants with the highest mean level also had
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Figure 5 Sensitivity analyses of latent class models in the OHTS data. Plots A and B: the observed mean IOP during follow-up visits of the
latent classes and the corresponding Kaplan-Meier POAG-free curves in the non-Black participants; Plots C and D: the observed mean IOP during
follow-up visits of the latent classes and the corresponding Kaplan-Meier POAG-free curves in the untreated participants.
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the largest IOP variability. Interestingly, despite the
marked differences between EGPS and OHTS in the
treatment intervention and magnitude of IOP lowering
achieved, both studies showed that adding IOP change
into the baseline model improved the overall predictive
accuracy for POAG development.
Conventionally the change of longitudinal data is
described using linear mixed models with random coefficients [31]. Though the mixed model recognizes the heterogeneous nature of the data by allowing each
individual to have his/her own intercept and slope, it
assumes that all individuals come from a single population and uses an average trajectory for the entire population. A LCA analyzes data from a rather different
perspective. The model approximates the unknown heterogeneity in the distribution of longitudinal outcome
using a finite number of polynomial functions each describing a unique subpopulation [14,32]. It classifies
individuals into distinct groups based on the patterns of
longitudinal outcome, so that individual within a group
are more similar than those between different groups.
This LCA possesses some unique advantages as comparing to conventional methods. First, the model lends itself
directly to a set of well characterized subpopulations
and also provides a formal statistical procedure to determine the appropriate number of subpopulations. It thus
enables the discovery of unexpected yet potentially
meaningful subpopulations that may be otherwise
missed with conventional methods. Second, the method
permits one to relate the developmental patterns of longitudinal data to its antecedents (predictors or covariates) and consequences (clinical outcomes), and thus
allows estimation of both direct and indirect (via longitudinal data) effects of a covariate on the distant outcome [16,23]. Finally, the recent advances of the dual
trajectory modeling also allow investigators to assess the
joint evolution of multiple longitudinal processes, which
may evolve contemporaneously or over different time
periods [32].
LCA also provides an attractive alternative for making
prediction with time-dependent covariates [21,22]. A
LCA takes a joint modeling approach to assess the association between longitudinal and survival data and thus
uses information more efficiently, resulting less biased
estimates. Unlike the conventional joint models that assess the association via shared random effects [19,33,34],
a LCA relates the longitudinal process to survival
process by latent classes and assumes the two stochastic
processes independent given the class membership [22].
Therefore, neither time-dependent covariates nor random effects of the longitudinal data are needed in the
survival sub-model. Such a model specification will
avoid the intensive computation to obtain the random
effects for new subjects and hence facilitates a real-time
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individualized prediction [21]. The key to build an accurate prediction in a LCA setting is to have a reliable classification given the observed data. Generally speaking,
the more the available serial biomarker readings, the
more reliable a classification is. To this consideration,
the impact of follow-up IOP on POAG may be overestimated in OHTS because an average length of 6.5-year
IOP readings was used to calculate the 5-year POAG-free
rate. To solve this dilemma, which is rather common in
all predictions involving time-dependent covariates, one
of the most frequently used approaches in medical literature is a landmark analysis that consists of fitting a serial
of survival models only to the subjects still at risk, that is,
computation of the predictive distribution at a certain
time given the history of event and covariates until that
moment [35]. In a LCA setting, such a dynamic prediction can be conveniently implemented because the conditional survival probability at any time can be calculated
analytically from a single LCA once the parameters are
estimated [21].
Despite its advantages, the LCA has several limitations. First, the computational load of LCA can be high,
especially for models with complexity structures. In
OHTS data (N = 1600), for example, it ran less than
10 minutes for an unconditional 6-class LCA, but it took
more than 30 minutes to develop the full conditional
model. Because of the exploratory nature of data analysis
with LCA, the cumulative time can be substantial. For
this consideration, in practice the best LCA model is
often constructed taking a two-step approach as in this
paper. Another issue in LCA is that the log-likelihood
function may end up at local rather than global maxima.
Fortunately this issue has been taken into consideration
by the statistical package Mplus which automatically
uses 10 sets of randomly generated starting values for
estimation. The program also allows investigators to rerun and compare the estimates from user specified starting values if necessary [23].

Conclusion
LCA provides a useful alternative to understand the
interrelationship among the baseline covariates, the
change in follow-up IOP, and the risk of developing
POAG. The inclusion of post-randomization IOP can improve the predictive ability of the original prediction
model that only included baseline risk factors.
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